Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SC0023
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
REACH Trial in Refractory Chronic Cough Completes Patient Enrollment
Details : SC0023 is an alkaline hypertonic divalent salt (HDS) aerosol, which is being evaluated for the treatment of refractory chronic cough (RCC).
Product Name : SC0023
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 14, 2025
Lead Product(s) : SC0023
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable